This inventor holds 1 USPTO granted patent. Top assignee: Bayer Intellectual Property Gmbh. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: The Innovative Journey of Kai Lovis
Introduction
Kai Lovis is a notable inventor based in Wuppertal, Germany. She has made significant contributions to the field of pharmaceuticals, particularly in the development of pan-CDK inhibitors. Her work is recognized for its potential impact on cancer treatment and other medical applications.
Latest Patents
Kai Lovis holds a patent for a process related to the preparation of pan-CDK inhibitors. The patent, titled "Process for preparing pan-CDK inhibitors of the formula (I), and intermediates in the preparation," outlines a novel method for synthesizing these important compounds. This innovation is crucial for advancing therapeutic options in oncology.
Career Highlights
Lovis is currently employed at Bayer Intellectual Property GmbH, where she continues to push the boundaries of pharmaceutical research. Her expertise in the field has led to the development of innovative solutions that address complex medical challenges.
Collaborations
Throughout her career, Kai has collaborated with esteemed colleagues, including Jörg Gries and Jorma Haßfeld. These partnerships have fostered a dynamic research environment that encourages the exchange of ideas and expertise.
Conclusion
Kai Lovis exemplifies the spirit of innovation in the pharmaceutical industry. Her contributions, particularly in the area of pan-CDK inhibitors, highlight her commitment to advancing medical science. Her work continues to inspire future generations of inventors and researchers.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile